期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

肾素-血管紧张素醛固酮系统与肾动脉狭窄

下载PDF
导出
摘要 肾动脉狭窄（RAS）所导致的肾血管性高血压，是继发性高血压常见病因之一，约占2％～5％.肾血管性高血压的发生主要是由于。肾血流的减少，导致肾素-血管紧张素．醛固酮系统（RAAS）被激活。目前已公认RAAS在肾动脉狭窄的病理生理过程中起重要作用，
作者 叶瑛 贾楠
机构地区 上海交通大学医学院 上海交通大学医学院附属瑞金医院高血压科上海市高血压研究所
出处 《临床内科杂志》 CAS 2011年第1期8-9,共2页 Journal of Clinical Internal Medicine
关键词 肾动脉狭窄 肾素-血管紧张素-醛固酮系统 血浆肾素活性 跨病变压力阶差
分类号 R692.16 [医药卫生—泌尿科学]
  • 相关文献

参考文献20

  • 1Goldblatt H,Lynch J,Hanzel RF, et al. Studies on experimental hypertension I : the production of persistent elevation of systolic blood pressure by means of renal ischemia. Exper Med, 1934,59:347-379.
  • 2Laragh JH, Sealey J, Brunner HR. The control of aldosterone secretion in normal and hypertensive man:abnormal renin-aldosterone patterns in low renin hypertension. Am Med, 1972,53:649-663.
  • 3Laragh JH. Vasoconstriction-volume analysis for understanding and trea- ting hypertension:the use of renin and aldosterone profiles. Am Med, 1973,55:261-274.
  • 4Chade AR, Zhu X, Lavi R,et al. Endothelial progenitor cells restore renal function in chronic experimental renovascular disease. Circulation, 2009,119:547-557.
  • 5Dworkin LD, Cooper CJ. Renal-Artery Stenosis. N Eng Med ,2009,361 : 1972-1978.
  • 6Zeller T, Muller C, Frank U, et al. Survival after stent-angioplasty of severe atherosclerotic ostial renal artery stenoses. Endovasc Ther,2003, 10:539-545.
  • 7Zeller T, Rastan A, Schwarzwalder U, et al. Regression of left ventricular hypertrophy following stenting of renal artery stenosis. JEVT,2007,14 : 189-197.
  • 8金智敏,赵晓薇,杨宏仁,唐树德,郭慧峰,王秦英,王继光.有效控制血压对高危高血压患者左室肥厚的长期影响[J].高血压杂志,2005,13(6):341-344. 被引量：14
  • 9Kalra PA,Green D, Cheung CM, et al. Medical therapy versus primary renal artery stenting-A twin centre study of outcome in atherosclerotic renovascular disease. Nephrol Dial Transplant,2007,22 : i8 (A).
  • 10Scarpioni R, Michieletti E, Cristinelli L, et al. Atherosclerotic renovascular disease:medical therapy versus medical therapy plus renal artery stenting in preventing renal failure progression:the rationale and study design of a prospective, muhicenter and randomized trail (NITER). Nephrol, 2005,18:423 -428.

二级参考文献5

  • 1WHO-ISH hypertension guidelines committee. 1999 world health organization-international society of hypertension guidelines for the management of hypertension[J]. J Hypertension, 1999,17:151-185.
  • 2Hansson L, Zanchetti A, Carruthers SG, et al. Effects of intensive blood pressure lowering and low-dose aspirin in patients with hypertension: principal results of the hypertension optimal treatment (HOT) randomised trial[J]. Lancet,1998,351 :1755.
  • 3Mancia G, Carugo S, Grassi G, et al. Prevalence of left ventricular hypertrophy in hypertensive patients without and with blood pressure control: data from the PAMELA population.Pressioni arteriose monitorate E loro associazioni[J]. Hypertension, 2002,39: 744-749.
  • 4Verdecchia P, Angeli F, Borgioni C, et al. Changes in cardiovascular risk by reduction of left ventricular mass in hypertension: a meta-analysis[J]. Am J Hypertens,2003,16:895-899.
  • 5Verdecchia P, Porcellati C, Reboldi G, et al. Left ventricular hypertrophy as an independent predictor of acute cerebrovascular events in essential hypertension[J]. Circulation, 2001,104: 2039-2044.

共引文献13

临床内科杂志
2011年 第1期

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部